Mevion Medical Systems

Mevion Medical Systems

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $70M

Overview

Mevion Medical Systems is a private medical device company specializing in compact proton therapy systems. Its flagship MEVION S250 Series is designed to reduce the size, complexity, and cost of proton therapy, making it a preferred choice for numerous leading cancer centers, including many NCI-Designated centers. The company has achieved significant commercial traction with multiple installations globally and has secured key regulatory clearances from the FDA and CE Marking for its latest S250-FIT system. Mevion's leadership combines deep industry experience with strong financial and entrepreneurial backgrounds, positioning the company to expand the adoption of proton therapy.

Oncology

Technology Platform

Compact proton therapy system (MEVION S250 Series) featuring HYPERSCAN pencil beam scanning for intensity-modulated proton therapy (IMPT), designed for a small footprint, high reliability (97% uptime), and lower capital/operating costs.

Funding History

2
Total raised:$70M
Series B$45M
Series A$25M

Opportunities

The growing global proton therapy market, especially among community hospitals and NCI-Designated Cancer Centers seeking cost-effective, compact solutions.
International expansion facilitated by CE Marking and demand for advanced cancer care in developing healthcare systems.

Risk Factors

Intense competition from larger, established medical device companies.
Dependence on favorable healthcare reimbursement policies for proton therapy.
Long and complex sales cycles for high-cost capital equipment, susceptible to hospital budget constraints.

Competitive Landscape

Mevion competes in the proton therapy market against major players like Varian Medical Systems (Siemens Healthineers) and Ion Beam Applications (IBA), which offer both large-scale and compact systems. Its primary differentiation is its claimed leadership in compact systems, with a focus on smaller footprint, lower cost, and high uptime, which has garnered significant adoption among NCI-Designated Cancer Centers.